Concurrently, a territorial branding strategy was implemented, accompanied by cultural events aimed at reclaiming public spaces and green areas
Category S0 (non-approved substances) covers pharmacological compounds without approval by any regulatory agency for use in humans
The effects of bee venom acupuncture on the central nervous system and muscle in an animal hSOD1G93A mutant
Key regulatory points for Epitalon Australia compliance: Epitalon is not approved by the Therapeutic Goods Administration (TGA) as a registered medicine for human or veterinary use It is classified strictly for laboratory and research purposes, not for human consumption Supply, import, and handling of research peptides fall under Australian regulatory oversight, and institutions should confirm current scheduling status directly through TGA resources before procurement Any research involving human subjects must comply with Research Ethics Committee approval and applicable Good Clinical Practice standards Marketing or supplying Epitalon with therapeutic claims, or implying suitability for human treatment, falls outside permitted research-use classifications Researchers and institutions should treat Epitalon strictly as a laboratory reagent, ensuring internal documentation, handling protocols, and communications consistently reflect its research-only status
Future clinical trials and pharmacokinetic assessments are needed to establish standardized guidelines for its safe and effective use alongside conventional therapies
